Most sponsors still optimize for the wrong variables. Jumo Health owns the one responsibility the traditional clinical trial model ignores: patient readiness as an operating discipline.
We don't just help you recruit more patients. We help ensure patients are prepared, supported, and able to participate through their last visit.
Powering studies for 17 of the top 25 global pharmaceutical companies by 2024 R&D spend.
It's time to flip the model and rethink patient experience.
Patient readiness should not be assumed. Jumo Health is a Patient Experience Organization purpose-built to solve what the industry keeps calling "dropout," "non-compliance," or "screen failure" when the real issue is unprepared participation. We combine behavioral science, health literacy, human-centered design, real-world data, and AI-enabled execution to determine:
What we determine
Which patients are most likely to advance and complete
Where participation is likely to break, and what is creating the friction
Which intervention is most likely to reduce it
When readiness is beginning to deteriorate, and where completion risk is accumulating across the study
Built deliberately, readiness changes the outcomes that matter:
Screen failures stop being accepted as "normal"
Enrollment becomes stable instead of volatile
Retention stops depending on heroics
Sites operate with less friction, and forecasting becomes credible
This changes patient experience from a collection of disconnected activities into a system of execution.
Today's studies face a behavioral crisis.
Participation is treated like a pipeline, not a personal journey.
High disease burden leaves patients emotionally paralyzed and overwhelmed
Protocols overwhelm, confuse, and repel before anyone explains them
Patients don't know who to trust
Providers lack the time and tools to guide the conversation
Caregivers are burned out and left out of decisions
Sites and study teams are stretched thin, without the materials or support to truly connect with patients
The result? Trials stall. Dropout rates climb. And far too often, the patients who could benefit most remain underrepresented.
This isn't a media problem. It's a readiness problem.
Not more media. Not better targeting. Not another technology. What gets deployed today optimizes activity and volume, and leaves readiness to chance.
What's being deployed today
What this creates
→One-size-fits-all static education and consent materials, delivered too late if at all
→Patients overwhelmed before they ever reach a site
→Recruitment platforms focused on pipeline volume and conversion rates, not preparedness
→Caregivers excluded from critical decisions
→Site teams forced to absorb readiness gaps under pressure
→HCPs without the time or tools to guide participation
→Engagement programs focused on activity, not decision quality
→Sites stretched thin, compensating for system failures
→AI applied to outreach, not understanding or commitment
→Sponsors reacting to problems that were decided months earlier
Readiness is the one thing no vendor has ever owned. That's the gap Jumo Health was built to close.
The Jumo Health PXO System: designed for today's study complexity.
Patient experience isn't solved with a single tool. It's built in layers: education, orchestration, and intelligence. Jumo Health enables patient readiness through two solutions, each designed to solve a different breakdown point in modern clinical trials.
CORE
Content for Onboarding & Readiness Education
Jumo Health's readiness education system.
It translates protocol complexity into the practical understanding patients, caregivers, families, and sites need, before and during participation.
CORE makes burden visible earlier. It aligns expectations before consent. It prepares caregivers before dependency becomes a barrier. It reinforces understanding as participation continues. The result is not a collection of materials. It is a structured readiness foundation.
Prepare patients before screening and consent
Translate clinical complexity into practical understanding
Reduce fear, confusion, and cognitive overload
Support caregiver and family decision-making
Deliver culturally and linguistically appropriate education
Materials deliver information. CORE prepares people to make and sustain an informed decision.
Activity can look healthy while execution is already breaking. Conventional education optimizes for output, not comprehension over time, which is the gap CORE was built to close.
Agencies
Campaign-first, not experience-first
Agencies optimize for messages and assets, not comprehension over time.
Inconsistent depth and durability
Education varies by brief, budget, and timeline, then disappears.
Measured on delivery, not understanding
Success stops at launch, not at readiness.
DIY
Fragmented and resource-constrained
Education is built piecemeal alongside other priorities.
Hard to scale or reuse
Each study starts from scratch with little compounding value.
No system of learning
Insights don't accumulate or improve future efforts.
CROs
Execution-focused, not education-led
CROs assume patients arrive prepared.
Education pushed downstream to sites
Adds burden to already stretched teams.
Reactive to failure
Problems are managed after they surface, not prevented upstream.
CORE builds comprehension as infrastructure, so understanding is engineered before consent, not assembled after it breaks.
PRISM
Patient Readiness & Intelligence System
Readiness as infrastructure.
PRISM turns patient experience into a measurable, predictive, operational asset. It makes readiness predictable instead of reactive.
PRISM identifies eligible patients, evaluates the conditions affecting advancement and completion, exposes the barriers most likely to interrupt participation, and orchestrates the interventions required to improve readiness. It does not stop at referral or enrollment. It monitors for burden accumulation, disengagement, behavioral friction, and emerging completion risk throughout the patient journey.
Identify eligible patients using claims, EMR, EHR, lab, and genetic data, plus social and behavioral determinants
Assess structural, cognitive, emotional, and behavioral readiness
Prioritize patients by likely activation, persistence, and completion
Deliver governed conversational education and intervention
Monitor readiness and retention risk, intervening before predictable failure becomes withdrawal
Recruitment fills the funnel. PRISM determines whether the funnel will hold.
Clinical trials still manage patients like pipeline inventory. Every conventional approach optimizes movement through the funnel. None govern whether patients are ready to finish, which is the gap PRISM was built to close.
Site-Led Recruitment
One size fits all
Education, screening, and stabilization are forced into the same moment.
Burns out the scarcest resource in trials
Highly trained staff spend time fixing unreadiness instead of running studies.
Finds failure after it's already expensive
Screen failure and dropout are discovered too late to prevent damage.
Digital Recruitment
Confuses interest with intent
Awareness scales. Readiness does not.
Optimizes volume at the expense of performance
More leads create more noise, not better patients.
Runs trials like marketing campaigns
Short-term clicks cannot support long-term participation.
AI Agents
Make unreadiness move faster
Automation accelerates patients into workflows they don't yet understand.
Assume humans behave like systems
Fear, fatigue, and caregiver dynamics don't follow scripts.
Optimize tasks, not outcomes
Efficiency improves while failure rates stay the same.
PRISM governs readiness instead of accelerating unreadiness, so the patients who enter your trial are the ones prepared to finish it.
One philosophy. Two entry points.
Start with education. Scale to intelligence. Or deploy the complete system from day one.
CORE builds the foundation through
Comprehension, expectation alignment, caregiver preparation, health literacy, participation education, and reinforcement, a faster entry point for improving patient and caregiver preparation without a broader system transformation.
PRISM governs progression through
Prediction, prioritization, friction detection, orchestration, risk monitoring, and completion intelligence, operationalizing readiness across identification, engagement, advancement, participation, and completion.
Who benefits when readiness is governed?
Readiness doesn't help one stakeholder at the expense of another. When it's built deliberately, every participant in the trial comes out ahead.
Patients
Understand before saying yes
Clear, sequenced education sets expectations before consent, not after.
Feel supported, not overwhelmed
Guidance matches where they are emotionally and cognitively.
Finish what they start
Fewer dropouts driven by fear, confusion, or fatigue.
HCPs
Better-prepared patients in the room
Baseline understanding is already established, so conversations go further with less re-education.
Higher-quality referrals
Patients arrive informed and aligned, not just interested.
Stronger trust
Education reinforces clinical guidance rather than undermining it.
Sites
Less education burden
Foundational explanations happen upstream, so screening is faster and more productive.
Standardized education means fewer gaps, missed visits, and rescue scenarios.
Sponsors
Higher-quality demand entering trials
Patients self-select with clearer expectations, cutting screen failure and early dropout.
Higher return on recruitment spend
Less wasted volume, more productive patients, more reliable timelines.
Reusable readiness infrastructure
Education assets and insights compound across studies, lowering trial risk over time.
Built for the trials where readiness matters most.
Biopharma portfolios where volatility compounds. Biotech sponsors betting everything on one pivotal. Rare, pediatric, and high-burden studies where a single preventable dropout costs months.
What does a Patient Experience Organization do for clinical trials?
A PXO designs and governs the experiences that decide whether patients can realistically finish a trial. Jumo Health created the category in 2009 and has led it since.
What is patient readiness?
How structurally, cognitively, and behaviorally prepared a patient is to finish a trial. Jumo treats it as measurable, not a sentiment.
Why do clinical trials experience high dropout?
Most dropout traces to unmanaged execution gaps: generic materials, unaddressed burden, excluded caregivers, and fear that surfaces after consent. All predictable once readiness is measured.
How is Jumo different from patient recruitment companies?
Recruitment companies optimize for leads and enrollment volume. Jumo optimizes for completion. We measure readiness, build understanding, and predict who will finish so readiness feeds your retention strategy.
How does CORE prepare patients for clinical trial participation?
CORE is a protocol-derived content library. It produces trial-specific, behaviorally structured, IRB-ready materials across the full lifecycle: videos, websites, brochures, HCP and site tools, in 72 languages.
How does PRISM predict patient readiness?
PRISM scores each eligible patient's baseline readiness from real-world, social, and behavioral data, then applies SPUR, COM-B, and Fogg to lift it through engagement, education, and prescreening.
Can CORE be purchased without PRISM?
Yes. CORE stands alone for sponsors closing execution gaps without a full readiness system. It's also the content layer inside PRISM.
What outcomes does readiness produce?
Across PRISM-governed studies: 56 percent fewer screen failures, 64 percent less time to last patient in, 96 percent higher completion. Results vary by phase, indication, and population.
